Skip to main content
Skip to footer
About
Active Biotech in Brief
Management
Board of Directors
Goals and Strategy
Corporate Governance
Corporate Governance Report 2025
Article of Association
General Meetings
Audit committee
Scientific committee
Election Committee
Auditors
Projects
Our projects
Tasquinimod
Laquinimod
Naptumomab
Patents
Clinical Studies
Investor
Overview
Analyses and Presentations
Financial Calendar
Financial Reports
Shareholders
Events
Rights Issues
Rights Issue 2025
Media
Overview
Press Contact
Press Releases
Contact
Svenska
Extraordinary General Meeting 2025
General Meetings
Date: 2025-11-19
2025
19
Nov
Minutes from Extraordinary General Meeting November 19, 2025
Press release: Extraordinary General Meeting of Active Biotech AB
Notice of Extraordinary General Meeting 2025
Proxy form
The board’s revised new issue decision
Board report
Auditor statement
Proposal for new Articles of Association
